Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trialAli Asadirad, Sajad Dehnavi, Azam Aminian et al.|Phytotherapy Research|2022Cited by 51